Use of single-nucleotide polymorphisms (SNPs) to distinguish gene expression subtypes of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME). — CFSMEATLAS
Use of single-nucleotide polymorphisms (SNPs) to distinguish gene expression subtypes of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME).
Shimosako, Nana, Kerr, Jonathan R · Journal of clinical pathology · 2014 · DOI
Quick Summary
This study looked at small variations in DNA (called SNPs) from people with ME/CFS to see if these genetic differences could help identify different subtypes of the condition. Researchers compared DNA from 108 ME/CFS patients with 17 people with depression and 68 healthy people. They found that certain genetic variations were more common in ME/CFS patients and that different combinations of these variations appeared to match different subtypes of the illness.
Why It Matters
ME/CFS lacks a reliable biological diagnostic test, making this research important because it explores whether genetic markers could eventually help diagnose the condition and distinguish between different subtypes that may respond differently to treatment. Identifying genetic subtypes could improve patient management by enabling more targeted therapeutic approaches based on individual genetic profiles.
Observed Findings
21 SNPs showed significant association with CFS/ME compared to depression and normal control groups
148 SNP alleles were significantly associated with one or more CFS/ME subtypes
Associated SNPs for each subtype tended to cluster within particular genes rather than being randomly distributed
Ancestry analysis identified 4 subjects of Asian origin among the 193 total subjects
Hierarchical clustering revealed genetic relatedness in 2 couples and overall heterogeneity across subjects
Inferred Conclusions
Human SNPs within CFS/ME-associated genes show differential associations with particular genomic subtypes of the condition
Genetic variation patterns may have potential to distinguish ME/CFS subtypes with distinct clinical characteristics
The heterogeneity of genetic profiles suggests ME/CFS comprises multiple genetically distinct subtypes
Further development is required to translate SNP associations into clinically useful diagnostic and subtype-stratification tools
Remaining Questions
How do these SNP associations relate to the actual gene expression changes previously reported by the authors, and do SNP patterns predict functional differences in gene expression?
What This Study Does Not Prove
This study does not prove that these genetic variations cause ME/CFS, only that they are associated with it—the underlying mechanism remains unknown. The study also does not demonstrate clinical utility; while SNP patterns correlate with subtypes, the authors explicitly state that further work is needed before this could become a practical diagnostic test. Additionally, the findings are limited to the specific population studied and would require validation in independent, larger cohorts before drawing broad conclusions.